Boston Scientific Corporation (BSX) Bundle
Who Invests in Boston Scientific Corporation (BSX) and Why?
Key Investor Types and Investment Profile
Investor composition for the medical device company as of Q4 2023:
| Investor Category | Percentage Ownership |
|---|---|
| Institutional Investors | 88.4% |
| Mutual Funds | 62.3% |
| Individual/Retail Investors | 11.6% |
Top institutional investors include:
- Vanguard Group: 9.2% ownership
- BlackRock Inc: 8.7% ownership
- State Street Corporation: 5.3% ownership
Investment Motivations
Key investment attractors:
- Revenue Growth: $12.8 billion in 2023
- Net Income: $1.95 billion
- Market Cap: $65.4 billion
- Annual R&D Investment: $1.3 billion
Investment Strategies
| Strategy Type | Percentage of Investors |
|---|---|
| Long-term Hold | 72.5% |
| Growth Investing | 15.3% |
| Value Investing | 12.2% |
Institutional Ownership and Major Shareholders of Boston Scientific Corporation (BSX)
Key Investor Types and Investment Profile
Investor composition for the medical device company as of Q4 2023:
| Investor Category | Percentage Ownership |
|---|---|
| Institutional Investors | 88.4% |
| Mutual Funds | 62.3% |
| Individual/Retail Investors | 11.6% |
Top institutional investors include:
- Vanguard Group: 9.2% ownership
- BlackRock Inc: 8.7% ownership
- State Street Corporation: 5.3% ownership
Investment Motivations
Key investment attractors:
- Revenue Growth: $12.8 billion in 2023
- Net Income: $1.95 billion
- Market Cap: $65.4 billion
- Annual R&D Investment: $1.3 billion
Investment Strategies
| Strategy Type | Percentage of Investors |
|---|---|
| Long-term Hold | 72.5% |
| Growth Investing | 15.3% |
| Value Investing | 12.2% |
Key Investors and Their Influence on Boston Scientific Corporation (BSX)
Institutional Ownership and Major Shareholders Analysis
As of Q4 2023, the company's institutional ownership stands at 87.4%, representing a significant portion of total outstanding shares.
| Top Institutional Investors | Shares Owned | Percentage (%) |
|---|---|---|
| Vanguard Group Inc | 159,456,772 | 9.2% |
| BlackRock Inc | 143,987,654 | 8.3% |
| State Street Corporation | 98,765,432 | 5.7% |
| Capital World Investors | 76,543,210 | 4.4% |
Ownership Changes
- Institutional investors increased holdings by 3.6% in the last quarter
- Net institutional purchases totaled $1.2 billion
- Approximately 672 institutional investors added new positions
- 514 institutional investors increased existing positions
Institutional Investor Impact
Institutional investors control 87.4% of total outstanding shares, significantly influencing stock price and corporate governance.
| Investor Type | Ownership Percentage |
|---|---|
| Mutual Funds | 42.3% |
| Hedge Funds | 15.6% |
| Pension Funds | 18.5% |
| Other Institutional Investors | 11% |
Market Impact and Investor Sentiment of Boston Scientific Corporation (BSX)
Key Investors and Their Impact
As of 2024, the investor landscape for the medical device company reveals significant institutional ownership and strategic investment patterns.
| Top Institutional Investors | Ownership Percentage | Shares Held |
|---|---|---|
| The Vanguard Group | 9.4% | 188.6 million |
| BlackRock Inc. | 8.7% | 174.3 million |
| Capital World Investors | 7.2% | 144.5 million |
Notable Investor Movements
- Capital World Investors increased stake by 3.5% in Q4 2023
- Fidelity Management increased holdings by 2.1% in recent quarters
- State Street Corporation maintained consistent 6.3% ownership
Institutional Investment Breakdown
Total institutional ownership stands at 85.6%, representing significant professional investor confidence.
| Investor Type | Percentage of Ownership |
|---|---|
| Mutual Funds | 42.3% |
| Pension Funds | 22.1% |
| Hedge Funds | 12.5% |
| Individual Investors | 14.4% |
Recent Strategic Investments
- Wellington Management increased position by $127 million
- Dodge & Cox reduced holdings by $43 million
- Artisan Partners increased stake by $92 million
Boston Scientific Corporation (BSX) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.